Trump Administration Executive Order (EO) Tracker
Dr. Philipp Glockemann
Associate Global Regulatory
Languages
German, English
-
Overview
-
Experience
-
Credentials
-
Insights and events
As a member of the SOAR team (Strategic, Operations, Agreements, and Regulation), Philipp Glockemann advises national and international pharma and biotech companies, medical device manufacturers and other innovative stakeholders in the life sciences industry.
Philipp's practice covers complex regulatory and strategic issues in all phases of drug and medical device development, from initial research and clinical development through to market access and distribution. He also assists with marketing compliance and interactions with healthcare professionals. Philipp further assists in drafting and negotiation of clinical trial agreements and commercial contracts. With his knowledge and practical expertise, Philipp helps clients effectively navigate the complex regulatory landscape, mitigate risk and capitalise on opportunities for innovation and growth.
During his time as a legal trainee, Philipp gained valuable experience in transactional law and regulated industries. While working on his doctoral thesis, Philipp centered his in-depth research and analyses on the laws and regulations governing statutory health insurance in Germany.
Representative experience
Advising SHI funds and medical aids providers regarding German statutory health insurance law, as well as proceedings before the social courts in the area of statutory health insurance.
Advising a U.S. pharmaceutical company on compliance issues and reviewing marketing material.
Advising a medical devices company in drafting and amending MDAs and Intercompany Agreements.
Advising medical device manufacturers on the Medical Device Regulation.
Advising pharmaceutical companies on the Paediatric Regulation, especially on PIPs.
Advising a manufacturer of APIs and a manufacturer of medical devices in their communication with regulatory authorities regarding a (global) recall and other FCAs.
Advising a U.S. biopharmaceutical company on product launch of medicinal products for primary care and rare diseases.
Credentials
Education
- Dr. iur., Doctorate in Law, University of Hamburg, 2024
- Second State Exam in Law, Higher Regional Court of Hamburg, 2024
- First State Exam in Law, University of Göttingen, 2020